H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Price:
0.325
HKD
-1.52%
Market Closed
Market Cap:
HK$167.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Huakang Biomedical Holdings Co Ltd
HKEX:8622
|
HK |
|
E
|
Encanto Potash Corp
XTSX:EPO.H
|
CA |
|
C
|
Central African Gold Inc
OTC:NDENF
|
CA |
|
Y
|
Yuzhou Group Holdings Co Ltd
OTC:YUZHF
|
CN |
|
C
|
China Oil and Gas Group Ltd
HKEX:603
|
HK |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
Jeevan Scientific Technology Ltd
BSE:538837
|
IN |
|
J
|
Jardine Matheson Holdings Ltd
LSE:JAR
|
HK |
Balance Sheet
Balance Sheet Decomposition
Huakang Biomedical Holdings Co Ltd
Huakang Biomedical Holdings Co Ltd
Balance Sheet Decomposition is not available for
Huakang Biomedical Holdings Co Ltd
Huakang Biomedical Holdings Co Ltd
Balance Sheet
Huakang Biomedical Holdings Co Ltd
Huakang Biomedical Holdings Co Ltd
Currency: CNY
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
6
|
16
|
20
|
55
|
49
|
42
|
36
|
33
|
33
|
31
|
37
|
|
| Cash |
6
|
16
|
20
|
55
|
49
|
42
|
36
|
33
|
33
|
31
|
37
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
5
|
|
| Total Receivables |
11
|
11
|
14
|
11
|
11
|
10
|
12
|
16
|
16
|
14
|
12
|
|
| Accounts Receivables |
7
|
9
|
10
|
11
|
10
|
10
|
9
|
9
|
9
|
10
|
10
|
|
| Other Receivables |
4
|
2
|
4
|
0
|
1
|
1
|
2
|
6
|
6
|
4
|
2
|
|
| Inventory |
2
|
2
|
2
|
2
|
3
|
3
|
4
|
3
|
3
|
3
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
4
|
2
|
1
|
1
|
1
|
0
|
|
| Total Current Assets |
20
|
30
|
36
|
70
|
63
|
59
|
54
|
53
|
53
|
55
|
57
|
|
| PP&E Net |
5
|
6
|
10
|
11
|
12
|
11
|
10
|
8
|
10
|
9
|
9
|
|
| PP&E Gross |
0
|
0
|
0
|
11
|
12
|
11
|
10
|
8
|
10
|
9
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
4
|
5
|
10
|
11
|
13
|
14
|
15
|
0
|
|
| Intangible Assets |
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
2
|
1
|
1
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Total Assets |
27
N/A
|
37
+36%
|
48
+29%
|
83
+72%
|
79
-6%
|
73
-8%
|
67
-8%
|
66
-1%
|
65
-2%
|
65
0%
|
67
+2%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
8
|
3
|
3
|
3
|
5
|
7
|
5
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
9
|
11
|
10
|
3
|
2
|
4
|
4
|
4
|
5
|
5
|
10
|
|
| Total Current Liabilities |
10
|
13
|
11
|
12
|
7
|
9
|
9
|
10
|
13
|
11
|
15
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
12
N/A
|
13
+13%
|
11
-17%
|
12
+13%
|
8
-35%
|
11
+35%
|
9
-14%
|
10
+6%
|
14
+45%
|
11
-22%
|
15
+39%
|
|
| Equity | ||||||||||||
| Common Stock |
3
|
3
|
0
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
|
| Retained Earnings |
12
|
21
|
37
|
20
|
20
|
11
|
7
|
4
|
2
|
7
|
47
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
47
|
47
|
47
|
47
|
49
|
50
|
57
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
16
N/A
|
24
+53%
|
37
+54%
|
71
+90%
|
71
0%
|
62
-12%
|
58
-7%
|
57
-2%
|
51
-10%
|
54
+6%
|
51
-5%
|
|
| Total Liabilities & Equity |
27
N/A
|
37
+36%
|
48
+29%
|
83
+72%
|
79
-6%
|
73
-8%
|
67
-8%
|
66
-1%
|
65
-2%
|
65
0%
|
67
+2%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
300
|
300
|
300
|
400
|
400
|
400
|
400
|
414
|
418
|
500
|
515
|
|
Switch to:
Switch to:
See Also
Discover More
